The growing interest in successful weight management has led to considerable research into cutting-edge treatments. Recently , Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor stimulator, has demonstrated encouraging results in patient trials, suggesting potential for considerable weight reduction .